Aclarion, Inc. (ACON)
NASDAQ: ACON · Real-Time Price · USD
7.50
-0.14 (-1.83%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Aclarion Revenue
In the year 2024, Aclarion had annual revenue of $45.72K, down -39.36%. Aclarion had revenue of $10.23K in the quarter ending December 31, 2024, a decrease of -25.84%.
Revenue (ttm)
$45.72K
Revenue Growth
-39.36%
P/S Ratio
95.65
Revenue / Employee
$7,621
Employees
6
Market Cap
4.37M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
ACON News
- 4 days ago - Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 - GlobeNewsWire
- 6 days ago - Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis - GlobeNewsWire
- 18 days ago - Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub - GlobeNewsWire
- 25 days ago - Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California - GlobeNewsWire
- 27 days ago - Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives - GlobeNewsWire
- 6 weeks ago - Aclarion Provides Shareholder Update - GlobeNewsWire
- 7 weeks ago - Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey - GlobeNewsWire
- 7 weeks ago - Aclarion Announces First Commercial Agreement with Scripps Health - GlobeNewsWire